PharMerica Corporation
PMC
PMC was delisted on the 7th of December, 2017.
0 hedge funds and large institutions have $0 invested in PharMerica Corporation in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 150 closing their positions.
100% less funds holding
Funds holding: 150 → 0 (-150)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $827M → $0 (-$827M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 150
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$117M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$76.5M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$50.8M |
| 4 |
WIC
Water Island Capital
New York
|
-$42.8M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
-$42.1M |
PMC Hedge Fund Activity: Q4 2017 in Review
0 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in PharMerica Corporation (PMC) for Q4 2017, worth a combined $0 — down 100% from $827M a quarter earlier.
Sellers outnumbered buyers: 150 funds closed out of PMC and 0 opened new positions — a net loss of 150 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was BlackRock, exiting entirely with an estimated $117M sold.
- 0 institutional investors held PharMerica Corporation (PMC) as of Q4 2017, down from 150 in Q3 2017.
- Funds reported $0 of PharMerica Corporation stock for Q4 2017, down 100% quarter-over-quarter.
- 0 funds opened new PharMerica Corporation positions in Q4 2017 and 150 closed out, a net change of -150 holders.
- The largest PharMerica Corporation seller in Q4 2017 was BlackRock, an estimated $117M sold.
Based on aggregated 13F filings for Q4 2017.